Citation Impact
Citing Papers
Impact of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography (PET) Alone on Expected Management of Patients With Cancer: Initial Results From the National Oncologic PET Registry
2008
Colorectal cancer statistics, 2020
2020 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
MR imaging of the her2/neu and 9.2.27 tumor antigens using immunospecific contrast agents
2004
Shedding light onto live molecular targets
2003 Standout
The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers
2007
Novel radiolabeled antibody conjugates
2007
Preparation and characterization of paramagnetic polychelates and their protein conjugates
1990
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
1991 Standout
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
2003 Standout
A comprehensive map of molecular drug targets
2016 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
New radiopharmaceuticals and new applications in medicine
1993
Attachment of oligosaccharides to peptide antigen profoundly affects binding to major histocompatibility complex class II molecules and peptide immunogenicity
1994 StandoutNobel
Production and Applications of Copper-64 Radiopharmaceuticals
2004
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging
2003
Cancer Statistics, 2006
2006 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Improving de novo protein binder design with deep learning
2023 StandoutNobel
American Thyroid Association Statement on Preoperative Imaging for Thyroid Cancer Surgery
2014
Photosensitizer-antibody conjugates for detection and therapy of cancer
2003
Expression of an antibody Fv fragment in myeloma cells
1988 StandoutNobel
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
2009
Specific MR imaging of human lymphocytes by monoclonal antibody‐guided dextran‐magnetite particles
1992
Diagnostic and therapeutic applications of monoclonal antibodies in colorectal cancer
1998
Cancer nanotechnology: opportunities and challenges
2005 Standout
Dendrimers in biomedical applications—reflections on the field
2005 Standout
Polymer conjugates as anticancer nanomedicines
2006 Standout
Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy
2010 Standout
Antibody-based imaging strategies for cancer
2014
Positron emission tomography and positron emission tomography‐CT evaluation for recurrent papillary thyroid carcinoma: Meta‐analysis and literature review
2010
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Luminescent metal–organic frameworks
2009 Standout
Magnetic resonance imaging of esophageal squamous cell carcinoma using magnetite particles coated with anti-epidermal growth factor receptor antibody
1998
In vitro and in vivo evaluation of 64Cu-TETA-Tyr3-octreotate. a new somatostatin analog with improved target tissue uptake
1999
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Monoclonal antibody‐coated magnetite particles as contrast agents in magnetic resonance imaging of tumors
1989
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Ligand-targeted therapeutics in anticancer therapy
2002
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Imaging Angiogenesis: Applications and Potential for Drug Development
2005
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.
1987
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
1999 Standout
Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents
1994 StandoutNobel
Aberrant Glycosylation In Tumors And Tumor-Associated Carbohydrate Antigens
1989
The dawning era of polymer therapeutics
2003 Standout
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
2000
Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications
1999 Standout
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
Oligomerization of Paramagnetic Substrates Result in Signal Amplification and can be Used for MR Imaging of Molecular Targets
2002
Comparison of Four 64Cu-Labeled Somatostatin Analogues in Vitro and in a Tumor-Bearing Rat Model: Evaluation of New Derivatives for Positron Emission Tomography Imaging and Targeted Radiotherapy
1999
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Stimuli-reponsive polymers and their bioconjugates
2004 Standout
Oligomerization of Paramagnetic Substrates Result in Signal Amplification and Can be Used for MR Imaging of Molecular Targets
2002
A phase II study of intraperitoneal radioimmunotherapy with iodine-131-labeled monoclonal antibody OC-125 in patients with residual ovarian carcinoma.
1999
Synthetic Strategies Toward N‐Functionalized Cyclens
2008
Pharmacokinetics of monoclonal immunoglobulin G1, F(ab')2, and Fab' in mice.
1986
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Assessment of the Incremental Value of Recombinant Thyrotropin Stimulation before 2-[18F]-Fluoro-2-Deoxy-d -Glucose Positron Emission Tomography/Computed Tomography Imaging to Localize Residual Differentiated Thyroid Cancer
2009
Molecular imaging and gene therapy.
2001
Dendrimers—Branching out from curiosities into new technologies
1998 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
About Dendrimers: Structure, Physical Properties, and Applications
1999 Standout
Aerobic Copper-Catalyzed Organic Reactions
2013 Standout
TARGETED CONTRAST AGENTS IN MR IMAGING
1996
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Synthesis, spectral, magnetic, electrochemical and catalytic studies of cyclam-based copper(II) and nickel(II) complexes–effect of N-substitution
2008
A new convenient synthesis of bifunctional chelating agent 1-(4-aminobenzyl)-1,4,8,11-tetraazacyclotetradecane-N′,N″,N‴-triacetic acid [1-(H 2 NBn-TETA)]
1998
Molecular Dynamics of Ion−Chelate Complexes Attached to Dendrimers
1996 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
An antibody-desferrioxamine conjugate labelled with 67Ga
1986
Stereoselective synthesis of the C-analogue of β-d-glucopyranosyl serine
1997 StandoutNobel
Surface molecular recognition
2001 StandoutNobel
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Site-Specific Polymer−Streptavidin Bioconjugate for pH-Controlled Binding and Triggered Release of Biotin
1999
Works of C. Curtet being referenced
Feasibility study of radioimmunoguided surgery of colorectal carcinomas using indium-111 CEA-specific monoclonal antibody
1990
Polylysine-Gd-DTPAn and Polylysine-Gd-DOTAn Coupled to Anti-CEA F(ab′)2 Fragments as Potential Immunocontrast Agents
1998
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma
2007
Gd-25 DTPA-MAb, a potential NMR contrast agent for MRI in the xenografted nude mouse: Preliminary studies
1988
Biodistribution of anti-CEA F(ab′)2 fragments conjugated with chelating polymers: Influence of conjugate electron charge on tumor uptake and blood clearance
1993
Site-specific conjugation of chain-terminal chelating polymers to Fab' fragments of anti-CEA mAb: Effect of linkage type and polymer size on conjugate biodistribution in nude mice bearing human colorectal carcinoma
1992
Feasibility and benefit of fluorine 18–fluoro-2-deoxyglucose–guided surgery in the management of radioiodine-negative differentiated thyroid carcinoma metastases
2005
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer.
1993
Immunoscintigraphy of recurrences of gynecologic carcinomas.
1987
Selective modification of NMR relaxation time in human colorectal carcinoma by using gadolinium-diethylenetriaminepentaacetic acid conjugated with monoclonal antibody 19-9.
1986
A convenient, novel approach for the synthesis of polyaza macrocyclic bifunctional chelating agents
1996
Two-step targeting of xenografted colon carcinoma using a bispecific antibody and 188Re-labeled bivalent hapten: biodistribution and dosimetry studies.
2001
Immunoscintigraphy of colon carcinoma.
1984
Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.
1989